Back to Treatments

Treatment

Fezolinetant

1
Conditions
17
Trials
7,000
Participants
65%
Average Safety

Condition Evidence

Menopause

17 trials · 7,000 participants

88% effectiveness · 65% safety
Fezolinetant | DFDA